Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
705 (USA) · Dr. Muller
consented 2012-09-07
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ABDOMINAL PAIN — outcome: RECOVERED/RESOLVED; onset 2012-09-19 (study day 13.0); relationship: REMOTE
severe
assessed
Severe COLON CANCER — outcome: RECOVERED/RESOLVED; onset 2013-01-21 (study day 137.0); relationship: NONE; serious criteria: hospitalization
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2011-12-05 (study day -277.0); relationship: PROBABLE
mild
assessed
Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2011-12-05 (study day -277.0); relationship: PROBABLE
Data queries
No data queries.